文献速递临床免疫临床生化

新型高亲和力抗NGAL单克隆抗体对用于急性肾损伤灵敏检测

Development of a novel high-affinity anti-NGAL monoclonal antibody pair for sensitive detection of acute kidney injury.
PubMed 文献 · Clin Chim Acta · 2026-04-01

本研究通过原核表达系统获得重组NGAL蛋白,免疫BALB/c小鼠后经杂交瘤技术筛选出4株NGAL特异性单克隆抗体,确定mAb-14/mAb-21为最佳抗体对,并初步建立磁微粒化学发光法(MPs-CLIA)和胶体金免疫层析法(GICA)。MPs-CLIA检测限为0.53 ng/mL,线性范围15.625-500 ng/mL,R²=0.9996,与商业试剂盒显著相关(R²=0.9489,rs=0.9499,P<0.0001),加标回收率92.08%-92.33%(CV<10%);GICA在临床血清样本中准确度97.5%,可检测至12.5 ng/mL。

要点

  • mAb-14/mAb-21为最佳NGAL抗体对,可建立MPs-CLIA和GICA两种检测方法。
  • MPs-CLIA检测限0.53 ng/mL,线性范围15.625-500 ng/mL,R²=0.9996。
  • GICA在临床血清样本中准确度97.5%,检测下限12.5 ng/mL。

核心结论

  • 建立的NGAL检测系统可满足从高灵敏定量到快速筛查的不同应用需求,为AKI早期诊断提供可靠技术方案。

研究设计与样本

  • 通过原核表达系统获得重组NGAL蛋白,免疫BALB/c小鼠后经杂交瘤技术筛选出4株NGAL特异性单克隆抗体,配对筛选确定mAb-14/mAb-21为最佳抗体对,并初步建立MPs-CLIA和GICA两种免疫学检测方法。

主要发现

  • MPs-CLIA检测限为0.53 ng/mL,检测范围15.625-500 ng/mL,R²=0.9996。
  • MPs-CLIA与商业试剂盒显著相关(R²=0.9489,rs=0.9499,P<0.0001)。
  • 加标样本回收率为92.08%-92.33%(CV<10%)。
  • GICA在临床血清样本中准确度为97.5%,可检测至12.5 ng/mL。

关键数值与推荐

  • MPs-CLIA检测限0.53 ng/mL,范围15.625-500 ng/mL,R²=0.9996。
  • 与商业试剂盒相关R²=0.9489,rs=0.9499,P<0.0001。
  • 加标回收率92.08%-92.33%,CV<10%。
  • GICA临床血清样本准确度97.5%,检测下限12.5 ng/mL。

临床怎么用

  • MPs-CLIA可用于NGAL的高灵敏定量检测,GICA可用于快速筛查,二者联合可满足AKI早期诊断的不同场景需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neutrophil Gelatinase-Associated Lipocalin (NGAL) is an early marker for Acute Kidney Injury (AKI) recommended by the International Society of Nephrology (ISN). This study obtained recombinant NGAL protein via a prokaryotic expression system. After immunizing BALB/c mice, four NGAL-specific monoclonal antibodies were screened using hybridoma technology. Through paired screening, mAb-14/mAb-21 was identified as the optimal antibody pair. Based on this, two immunological detection methods were preliminarily established: magnetic particle chemiluminescence assay (MPs-CLIA) and colloidal gold immunochromatography assay (GICA). According to the performance evaluation, MPs-CLIA exhibited a detection limit of 0.53 ng/mL across a range of 15.625-500 ng/mL, with a superb fit (R2 = 0.9996). It demonstrated a significant association with the commercial kit (R2 = 0.9489, rs = 0.9499, P < 0.0001). The recovery rate for spiked samples ranged from 92.08% to 92.33% (CV < 10%). In clinical serum samples, GICA obtained 97.5% accuracy and detected analytes down to 12.5 ng/mL. The established detection system addresses diverse application needs, ranging from highly sensitive quantification to rapid screening, and provides a reliable technical solution for the early diagnosis of AKI.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Liao N, Duan C, Liu J, et al. Development of a novel high-affinity anti-NGAL monoclonal antibody pair for sensitive detection of acute kidney injury. Clin Chim Acta. 2026. PMID: 41932421. doi:10.1016/j.cca.2026.120999

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。